Skip to content
Use caution Drug recall · FDA · Published September 5, 2025

Apotex Brimonidine/Timolol Eye Drops Recall: Sterility Risk

Apotex recalls 0.2%/0.5% eye drops due to potential sterility issues from improper sealing. Affected lots expire Dec 2025. Stop using if you have these specific sizes.

🇺🇸 FDA recall #D-0676-2025DrugApotex ›
Take action

Contact the company

Recalling firmApotex Corp.2400 N Commerce Pkwy Ste 400 · Weston, FL 33326-3253
✎ GovInfoNow plain-language explainer

Apotex is recalling two strengths of eye drops (0.2%/0.5%) that may not be sterile because of sealing problems. This could lead to infections if used improperly. People with prescriptions for these drops should check their lot numbers. Read more at govinfonow.com/recall/31799-apotex-brimonidine-timolol-eye-drops-recall-sterility-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31799-apotex-brimonidine-timolol-eye-drops-recall-sterility-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0676-2025

Cite this page

“Apotex Brimonidine/Timolol Eye Drops Recall: Sterility Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31799-apotex-brimonidine-timolol-eye-drops-recall-sterility-risk. Based on FDA recall #D-0676-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0676-2025%22&limit=1).

The FDA announced on Sept. 5, 2025, that Apotex Corp. is recalling Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution due to a lack of assurance of sterility caused by improper bottle sealing. Owners should contact the company for a refund.

How to tell if you have it

  • Brand: Apotex
  • Product: Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, Rx Only, Sterile
  • Sizes: 5 mL and 10 mL
  • NDC: 60505-0589-1 (5 mL), 60505-0589-2 (10 mL)
  • Lot codes: VE0614, VE0616
  • Expiration date: 12/2025
  • UPC: 00360505058914

The hazard

The recall addresses potential sterility concerns resulting from improper bottle sealing that led to atypical weight loss in the product. The FDA classified this as a Class II recall involving 151,034 bottles distributed nationwide.

Context

GovInfoNow's records show Apotex Corp. has 24 other recalls on record since June 14, 2007. Recent similar recalls include the Paroxetine 37.5mg recall due to dissolution failure (Sept. 23, 2026) and the Paxil CR 37.5mg Tablets recall for failed stability testing (Aug. 13, 2026). Other recent recalls of similar products include the Clear Eyes Eye Drops Recall: Lack of Sterility Risk (Sept. 15, 2026), the K.C. Pharmaceuticals Ultra Lubricating Eye Drops Recall: Lack of Sterility Risk (March 3, 2026), and the K.C. Pharmaceuticals Sterile Eye Drops AC Recall: Lack of Sterility Risk (March 3, 2026).

How to tell if you have this one

Check the product label for 'Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%'. Look for lot numbers VE0614 (5mL) or VE0616 (10mL) with expiration dates of December 2025.

  • Brand
    Apotex
  • Product
    Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide in the US
Recall numberProduct, codes & lotsQuantityNDC
D-0676-2025Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1 (5 mL), NDC 60505-0589-2 (10 mL).; a) lot # VE0614 exp. date 12/2025 UPC:(01)00360505058914 (5 mL) b) lot # VE0616 exp. date 12/2025 UPC:(01)0(03)60505058921 (10 mL)151,034 bottles60505-0589-1, 60505-0589-2, 60505-0589-3, 0036050505, 6050505892
D-0677-2025Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1.; Batch # VA0444, exp. date 01/2026 Batch # VA4608, exp. date 01/2026 Batch # TZ7016, exp. date 12/2025 UPC on Bottles: (01)0(03)60505100316 UPC on Cartons: 360505100316493,468 bottles60505-1003-1, 60505-1003-2, 6050510031, 3605051003
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for lot numbers VE0614 (5mL) or VE0616 (10mL) with expiration dates of December 2025.

  2. Discard if Affected

    If you have the recalled lot numbers, discard the eye drops immediately to avoid potential infection.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 33 days after the firm started it.

1. Firm started the recall: Sep 5, 202512. FDA classified it Class II: Sep 30, 202523. Published in FDA’s Enforcement Report: Oct 8, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Apotex recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0676-2025 (September 5, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0676-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA